GLP-1 receptor agonists × adverse events & safety

SynthesisDiabetes research and clinical practice2012

A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

Carlos Alves et al.PubMed ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with adverse events & safety

1.5×0.4× to 6×

Bigger than 7 in 10 for adverse events & safety

As reported

OR 1.54, 95% CI 0.40–6.02

One number in the abstract

the abstract, start to end

an increased risk for thyroid cancer (OR 1.54 [95% CI 0.40-6.02], I(2) = 0%).

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
OR 1.540.40–6.02
GLP-1 receptor agonistsAdverse events & safety
1 / 3

85 papers cite itlatest 60 shown

2012
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

11 trials

Full record →Abstract, authors, funding and every citing paper · PMID 23010561